SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is generating massive social media buzz and extreme volatility driven by a major executive order aimed at fast-tracking psychedelic research for PTSD and addiction. Community discussion is dominated by speculation over a potential short squeeze due to the stock's low float, with many retail traders highlighting its ibogaine supply chain as a key catalyst while others debate the risks of a volatility-driven pump.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant market volatility after a Blue Origin launch resulted in the BlueBird 7 satellite being placed into an unsustainably low orbit, leading to its required de-orbiting. While the company maintains that insurance will mitigate financial losses and that its broader constellation deployment roadmap remains intact, the community is actively debating the reliability of launch providers, the impact on launch cadence, and whether this setback represents a temporary operational hurdle or a deeper execution risk.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

crow with knife is generating intense community interest due to its unique multichain presence and deflationary burn mechanism. Supporters are actively rallying behind the project's organic growth and cultural identity, frequently encouraging others to increase their positions in what they describe as a community-driven movement.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing an aggressive short squeeze and significant volume surge, fueled by Bitcoin's recovery and optimism surrounding institutional accumulation. The community is sharply divided, with bulls celebrating the potential for rapid gains as the stock decouples from recent weakness, while skeptics continue to debate the long-term sustainability of the company's leverage and dividend strategy.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is experiencing a significant surge after Greenland authorities approved the transfer of a majority interest in the Tanbreez project, solidifying the company's 92.5% ownership of one of the world's largest heavy rare earth deposits. The community is actively discussing the stock's potential for a massive short squeeze and long-term valuation expansion, with many investors anticipating further upward momentum as the news de-risks the project and enhances its strategic importance for Western supply chains.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing a surge in bullish momentum as investors anticipate a strong earnings report and the potential for S&P 500 inclusion later this year. The community is heavily divided, with long-term shareholders holding firm for a recovery to previous highs while active traders engage in intense battles with short sellers amid significant call-option volume and volatility.

AEVEX Corp. operates as a holding company. It operates through Tactical Systems and Global Solutions segments. The Tactical Systems segment focuses on design, development, and production of autonomous systems including unmanned aerial systems and unmanned surface vessels. The Global Solutions segment offers services and mission support to defense and intelligence customers. The company was founded in 2017 and is headquartered in Solana Beach, CA.

AEVEX Corp. - Ordinary Shares - Class A

AEVEX Corp. is generating significant investor buzz following its recent NYSE IPO, with market participants closely monitoring the drone manufacturer due to its strong defense sector positioning and ongoing government contract activity. Community discussion is focused on the stock's high-volatility momentum, with traders actively comparing its growth potential to other defense technology players while debating the sustainability of its post-debut price action.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific is trending as investors focus on its pivot from Bitcoin mining to AI data center infrastructure and high-density compute hosting. The community is actively discussing the company's long-term potential supported by major power capacity contracts, alongside institutional accumulation and heavy call option activity.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors react to the company's global expansion efforts and potential regulatory catalysts, while the community remains fiercely divided over FDA relations and short-selling activity. Enthusiastic supporters are highlighting international clinical partnerships as a way to bypass domestic delays, while traders continue to closely watch for signs of a squeeze as discussions center on the company's long-term immunotherapy platform.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc. is capturing significant investor attention as it evolves into a full-stack 'Physical AI' platform following its acquisition of Stereolabs, with sentiment shifting toward its long-term potential in industrial automation, robotics, and smart infrastructure. Community discussions are currently dominated by analysis of the company's path to profitability, the strategic advantages of its sensor-software integration, and the impact of domestic sourcing policies on future market dominance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tudor Investment Corp ET AL Buys Shares of 65,964 Aurinia Pharmaceuticals Inc $AUPH

Tudor Investment Corp ET AL bought a new stake in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 65,964 shares of the biotechnology company's stock, valued...

Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 12-Month High - Here's What Happened

Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 52-Week High - Here's What Happened...

Ritholtz Wealth Management Acquires 174,301 Shares of Aurinia Pharmaceuticals Inc $AUPH

Ritholtz Wealth Management increased its holdings in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) by 206.2% in the fourth quarter, according to its most recent disclosure with...

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of "Hold" by Analysts

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Get Free Report) (TSE:AUP) has earned an average recommendation of "Hold" from the six analysts that are currently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have given a b...

JPMorgan Chase & Co. Grows Stock Holdings in Aurinia Pharmaceuticals Inc $AUPH

JPMorgan Chase & Co. grew its holdings in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) by 21.7% in the third quarter, according to its most recent filing with the Securities...

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs, announced today it...

<ul class="summary-bullets"><li>Michael Hearne has been appointed Chief Financial Officer, replacing Joe Miller.</li><li>Decision to remove Greenleaf and install Tang as CEO represents a “complete validation” of concerns raised for nearly three years, major shareholder MKT Capital said in a statement.</li><li>The company is looking to initiate a clinical study of Aritinercept for an autoimmune disease in the first half of 2026.&nbsp;</li></ul>Aurinia Pharmaceuticals (AUPH) drew strong retail interest on Monday after naming Kevin Tang as Chief Executive Officer, fueling investor hopes of a “new positive era” for the company.<a href="https://stocktwits.com/symbol/AUPH">AUPH stock</a> was up more than 6% at the time of writing.Tang, who is also the Chair of the Board, will replace Peter Greenleaf, who has been the company’s CEO for the past 7 years. Tang, an industry veteran, previously served as Chairman of La Jolla Pharmaceutical Company from 2014 through its acquisition by Innoviva in 2022.In 2013, Tang founded Odonate Therapeutics and served as its Chairman and CEO through 2022. Mr. Tang also co-founded Ardea Biosciences in 2006 and Heron Therapeutics in 2009. From 2009 through its acquisition by Keenova Therapeutics in 2010, Tang served as Director of Penwest Pharmaceuticals Co.Among other changes, Michael Hearne has been appointed Chief Financial Officer, replacing Joe Miller. Meanwhile, Ryan Cole was appointed as Chief Operating Officer, and Thomas Wei took over as Chief Scientific Officer.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment flipped to ‘bullish’ from ‘bearish,’ amid ‘high’ message volumes.<img src="https://news.stocktwits-cdn.com/AUPH_jpg_4ef07ce8ea.webp" alt="AUPH.jpg">One user speculated on the implications of the management change for the company, akin to the potential for it to go private.<stembedurl>https://stocktwits.com/US_Bull/message/648264487</stembedurl>Another user said, “Hopefully this starts the beginning of a new positive era”.<stembedurl>https://stocktwits.com/cjohoya/message/648275231</stembedurl>In 2021, Aurinia Pharmaceuticals launched LUPKYNIS, an FDA-approved oral treatment for adults with active Lupus Nephritis. The company also plans to begin a clinical study of Aritinercept for an autoimmune disease in the first half of 2026. Aurinia reported its first full-year profit in December 2024.<h2 class="st-heading-2">MKT’s Statement On Management Changes</h2>MKT Capital, a major long-term shareholder of Aurinia, issued a statement following the appointment of Kevin Tang as CEO.“Today marks a watershed moment for Aurinia shareholders. Since 2019, we have tirelessly advocated for accountability, disciplined capital allocation, and genuine alignment between management and the true owners of this Company – its shareholders. The Board’s decision to remove CEO Peter Greenleaf and his executive team, and to install Chair Kevin Tang as CEO, represents a complete validation of the concerns we have raised for nearly three years,” said Antoine Khalife, Founder of MKT Capital.In April 2025, MKT Capital announced its intention to withhold support for Greenleaf at the 2025 Annual General Meeting.Year-to-date, the stock has fallen 6.5%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/nvda-stock-200-dma-rebound-ai-factories-deal/cZ3mgN2RI0Z">NVDA Stock Rebounds But Remains Below Key Support For Second Session: Retail Sees Massive Upside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Aurinia Pharmaceuticals logo is seen displayed on a smartphone screen

AUPH Stock Rallies After CEO Shake-Up: Retail Bulls Bet On Turnaround

Aurinia Pharmaceuticals named Kevin Tang as its Chief Executive Officer, replacing Peter Greenleaf.

Equity

Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning

Aurinia Pharmaceuticals shares are trading higher Monday after announcing a leadership transition seen as a sign of continuity and strategy.read more...

Aurinia Announces Management Transition

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced today that Kevin Tang, Aurinias Chair of the Board, will succeed Peter Greenleaf as Chief Executive Officer. Peter will continue as a consultant...

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Passes Below 200-Day Moving Average - Here's What Happened

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Crosses Below 200-Day Moving Average - Time to Sell...

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

AUPH
Aurinia Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AUPH News

AUPHAurinia Pharmaceuticals Inc